Skip to Main Content

Paper Details

Renin-angiotensin aldosterone inhibitor use at hospital discharge among patients with moderate to severe acute kidney injury and its association with recurrent acute kidney injury and mortality.
Kidney Int
17
2021
AKI, RAASi, Renin-angiotensin aldosterone, acute kidney injury, aldosterone, chronic kidney disease, diabetes, heart failure, malignancy, patients
Acute Kidney Injury, Aldosterone, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Angiotensins, Hospitals, Humans, Patient Discharge, Renin, Retrospective Studies
Author NameAffiliation
Edward D SiewHealth Services Research and Development, USA VA Geriatrics Research Education and Clinical Center (GRECC), Vanderbilt Center for Kidney Disease (VCKD) and Integrated Program for Acute Kidney Injury Research (VIP-AKI), Vanderbilt University Medical Center
Sharidan K ParrHealth Services Research and Development, Vanderbilt Center for Kidney Disease (VCKD) and Integrated Program for Acute Kidney Injury Research (VIP-AKI), Vanderbilt University Medical Center
Khaled Abdel-KaderVanderbilt Center for Kidney Disease (VCKD) and Integrated Program for Acute Kidney Injury Research (VIP-AKI), Vanderbilt University Medical Center
Amy M PerkinsVA Geriatrics Research Education and Clinical Center (GRECC), Vanderbilt University Medical Center
Robert A GreevyHealth Services Research and Development, Vanderbilt University Medical Center, Clinical Sciences Research and Development
Andrew J VinczVanderbilt Center for Kidney Disease (VCKD) and Integrated Program for Acute Kidney Injury Research (VIP-AKI), Vanderbilt University Medical Center
Jason DentonHealth Services Research and Development, USA VA Geriatrics Research Education and Clinical Center (GRECC)
Otis D WilsonVanderbilt Center for Kidney Disease (VCKD) and Integrated Program for Acute Kidney Injury Research (VIP-AKI), Vanderbilt University Medical Center, Clinical Sciences Research and Development
Adriana M HungVanderbilt Center for Kidney Disease (VCKD) and Integrated Program for Acute Kidney Injury Research (VIP-AKI), Vanderbilt University Medical Center, Clinical Sciences Research and Development
Talat Alp IkizlerVanderbilt Center for Kidney Disease (VCKD) and Integrated Program for Acute Kidney Injury Research (VIP-AKI), Vanderbilt University Medical Center, Clinical Sciences Research and Development
Cassianne Robinson-CohenVanderbilt Center for Kidney Disease (VCKD) and Integrated Program for Acute Kidney Injury Research (VIP-AKI), Vanderbilt University Medical Center
Michael MathenyHealth Services Research and Development, USA VA Geriatrics Research Education and Clinical Center (GRECC), Vanderbilt University Medical Center
Michael E MathenyHealth Services Research and Development, USA VA Geriatrics Research Education and Clinical Center (GRECC), Vanderbilt University Medical Center
  • 1 - 13

Datasets

Release 1.2